
Armis Biopharma: A progressive biopharmaceutical company specializing in non-systemic drugs.
Armis Biopharma, founded with a mission to improve societal health by protecting humans, animals, and the environment from harmful pathogens, specializes in developing non-systemic drugs. Their core product, Veriox® Technology, is a potent antimicrobial and anti-toxin platform based on a proprietary peracid/hydrogen peroxide formulation. This technology offers a highly selective action against a wide range of bacterial and viral pathogens, verified by both government and private laboratories.
Notable figures associated with Armis Biopharma include experts in biopharmaceutical development and key investors committed to advancing healthcare innovations. The company's significant achievements include the successful independent verification of Veriox® Technology's efficacy, positioning it as a leading solution in pathogen elimination. Armis Biopharma's impact lies in its innovative approach to non-systemic treatments, contributing to enhanced public health and safety.

Armata Pharmaceuticals
armatapharma.com

ArrePath
arrepath.com

Armgo Pharma
armgo.com

Armr Systems
armrsystems.com

ExoLytics
exolytics.com

Innovative Biologics

BioPlx

Microbiotix
microbiotix.com

Arbutus Biopharma
arbutusbio.com

Anti-Microbial Solutions

Amicrobe
amicrobe.com

Verax Biomedical

Armetheon

Taxis Pharmaceuticals
taxispharma.com

Bioxiness Pharmaceuticals
Companies similar to Armis Biopharma include Armata Pharmaceuticals, ArrePath, Armgo Pharma and Armr Systems.
Armis Biopharma was founded in 1997.
Armis Biopharma's headquarters is located in Fort Collins, CO, US.
Armis Biopharma's most recent funding round was for $423k (USD) in November 2020.
As of Nov 9, 2020, Armis Biopharma has raised a total of $10.4M (USD).
Armis Biopharma has 11 employees as of Feb 5, 2024.